Login / Signup

Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor: A Single-Institution Experience (ID: PARROT Trial).

Giuseppe VizzielliMaria Teresa GiudiceFederica NardelliBarbara CostantiniVanda SalutariFrediano Socrate InzaniGian Franco ZannoniVito ChianteraAndrea Di GiorgioFabio PacelliAnna FagottiGiovanni Scambia
Published in: Annals of surgical oncology (2023)
PIPAC seems a feasible approach for the treatment of this subset of patients, without any impact on their quality of life. Since this study had a small sample size and a single-center design, future research is mandatory, such as its application in addition to systemic chemotherapy.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • locally advanced
  • study protocol
  • peritoneal dialysis
  • squamous cell carcinoma
  • current status
  • replacement therapy